Liposarcoma Clinical Trials

62 clinical trials for Liposarcoma across international registries, including 17 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors — RECRUITING · PHASE1
• NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) — RECRUITING · PHASE1
• Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors — RECRUITING · PHASE1
• A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas — RECRUITING · PHASE1
• A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma — RECRUITING · PHASE1
• Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma — RECRUITING · PHASE3
• Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients — RECRUITING
• Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells — RECRUITING · PHASE1
• Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma — RECRUITING · PHASE2
• Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. — RECRUITING · PHASE2
• Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells — RECRUITING · PHASE1
• MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma — RECRUITING · PHASE2
• APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors — RECRUITING · PHASE1
• Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas — RECRUITING · NA
• Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients — RECRUITING · PHASE1
• A PHASE 2 SINGLE ARM OPEN-LABEL CLINICAL TRIAL OF ADP-A2M4 SPEAR T CELLS IN SUBJECTS WITH ADVANCED SYNOVIAL SARCOMA OR MYXOID/ROUND CELL LIPOSARCOMA (SPEARHEAD 1 STUDY) — RECRUITING · PHASE2
• A PHASE 2-3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF SELINEXOR (KPT-330) VERSUS PLACEBO IN PATIENTS WITH ADVANCED UNRESECTABLE DEDIFFERENTIATED LIPOSARCOMA (DDLS) — RECRUITING · PHASE2
• Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery — ACTIVE_NOT_RECRUITING · PHASE2
• BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma — ACTIVE_NOT_RECRUITING · PHASE1
• Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery — COMPLETED · PHASE2
• Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery — ACTIVE_NOT_RECRUITING · PHASE1
• Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma — COMPLETED · PHASE1
• Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma — COMPLETED · NA
• A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas — COMPLETED · PHASE2
• NM32-2668 in Adult Patients With Selected Advanced Solid Tumors — TERMINATED · PHASE1
• Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery — COMPLETED · PHASE2
• The Registry of Oncology Outcomes Associated With Testing and Treatment — COMPLETED
• Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas — COMPLETED · PHASE2
• ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma — TERMINATED · PHASE2
• A PHASE III OPEN-LABEL, SINGLE-ARM, MULTI-CENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF BRIGIMADLIN (BI 907828) TREATMENT IN PATIENTS WITH TREATMENT-NAÏVE OR PRE-TREATED ADVANCED DEDIFFERENTIATED LIPOSARCOMA — COMPLETED · PHASE3
• Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors. — WITHDRAWN · PHASE1
• Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma — COMPLETED · PHASE2
• SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes — COMPLETED · PHASE2
• A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents — OTHER · PHASE1
• Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients — NOT_YET_RECRUITING
• Patient Reported Outcome Measures (PROMs) With Trabectedin — TERMINATED
• BRIGHTLINE-1: A PHASE II/III, RANDOMIZED, OPEN-LABEL, MULTI-CENTER STUDY OF BRIGIMADLIN (BI 907828) COMPARED TO DOXORUBICIN AS FIRST LINE TREATMENT OF PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA — COMPLETED · PHASE2
• Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma — WITHDRAWN · PHASE2
• Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma — COMPLETED · PHASE2
• A RANDOMIZED MULTICENTER PHASE 3 STUDY OF MILADEMETAN VERSUS TRABECTEDIN IN PATIENTS WITH DEDIFFERENTIATED LIPOSARCOMA — COMPLETED · PHASE3
• A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas — WITHDRAWN · PHASE2
• Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall — OTHER · PHASE2
• Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma — COMPLETED · PHASE1
• Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma — WITHDRAWN · PHASE1
• The FGF/FGFR Signalling Pathway: — COMPLETED
• Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) — TERMINATED · PHASE2

Refine this search